UMIC
INNODX
DRD
Wantai BioPharm
Controls & Standards
INNOBIOMAX
J&W
Innovax

Beijing Controls & Standards Biotechnology Co., Ltd.
Beijing Controls & Standards Biotechnology Co., Ltd., founded in 2009, has emerged as China's premier brand of third-party quality control solutions. Specializing in the R&D, production, and commercialization of reference materials, serum panels, and internal quality control products, the company is a high-tech enterprise that bridges cutting-edge innovation with real-world diagnostic applications. Backed by a dedicated R&D team, robust production systems, and a nationwide sales network, it has developed over 150 certified products, rigorously evaluated by China's national regulatory authorities. The company's excellence is underscored by its "National Reference Material Certification" awarded by the General Administration of Quality Supervision, Inspection and Quarantine and the State Administration for Market Regulation.
With the ongoing advancement of China's mutual recognition system for medical test results, laboratories across healthcare institutions are increasingly prioritizing standardized quality control. To ensure diagnostic reliability, they must rigorously validate testing accuracy, monitor internal QC processes, and scientifically evaluate method precision - fundamental requirements not only for achieving cross-hospital test reciprocity but also for enhancing healthcare efficiency and reducing patient burdens. Leveraging our strong R&D capabilities, extensive market experience, and mature QC system, we specialize in developing third-party quality control products tailored for diverse laboratory needs, while also providing complementary QC software, customized training programs, and ISO 15189 accreditation consulting services. Through these comprehensive solutions, we are committed to promoting nationwide standardization of medical testing, facilitating seamless result mutual recognition, and ultimately elevating overall healthcare quality.
